Skip to main content
. 2012 Mar 1;8(3):347–354. doi: 10.4161/hv.18630

Figure 2.

Figure 2.

Seroconversion rates for poliovirus types 1, 2 and 3 one month post-booster (ATP immunogenicity cohort). *Seroconversion was defined as post-booster antibody titer ≥ 1:8 in initially seronegative subjects, at least a 4-fold increase in post-booster titer in initially seropositive subjects, or a titer greater than the highest dilution tested [1:8192] in subjects with pre-booster antibody titers < 8192). Form 1 received DTPw-HBV-IPV(full dose)/Hib; Form 1/2 received DTPw-HBV-IPV(1/2 dose)/Hib; Form 1/3 received DTPw-HBV-IPV(1/3 dose)/Hib; Controls received DTPw-HBV/Hib Kft + IPV.